The National Institute of Neurological Disorders and Stroke (NINDS) encourages research on HIV infection of the central nervous system (CNS). This announcement is made together with 4 other components of the National Institutes of Health (NIH).
The introduction of highly active anti-retroviral therapy (HAART) has resulted in significantly improved survival of AIDS patients and decreased incidence of HIV-associated dementia. Despite the reduced incidence of HIV dementia, the improved survival has resulted in increased cumulative prevalence of nervous system complications of AIDS. While improvements in treatment for AIDS have occurred in the developed world, a significant number of new infections are being reported in developing countries. The neurological and neuropsychiatric complications resulting from new infections in the developing world are likely to cause significant disability and death.
For more information, potential applicants should contact Dr. Michael Nunn, Program Director, Neural Environment Cluster, NINDS; telephone: 301-496-1431; e-mail: email@example.com. For a more detailed description of this announcement, visit http://grants.nih.gov/grants/guide/pa-files/PA-07-089.html.